Bartlett, KieraKenning, CassandraCrosland, JackNewhouse, NikkiMiles, Lisa M.Williams, VeronikaMcSharry, JennyLocock, LouiseFarmer, Andrew J.French, David2021-06-302021-06-302021-06-28Bartlett, K, Kenning, C, Crosland, J, Newhouse, N, Miles, L M, Williams, V, McSharry, J, Locock, L, Farmer, A J & French, D 2021, 'Understanding acceptability in the context of a text message intervention to encourage medication adherence in people with type 2 diabetes : A mixed methods study', BMC Health Services Research, vol. 21, no. 1, 608. https://doi.org/10.1186/s12913-021-06663-21472-6963ORCID: /0000-0002-8109-1930/work/96307992https://hdl.handle.net/2164/16755Acknowledgements: The authors would also like to acknowledge the support of the University of Oxford Primary Care Clinical Trials Research Unit, Katherine Grady and the Research for the Future/Help BEAT campaigns (National Institute for Health Research [NIHR] Clinical Research Network Greater Manchester), Northern Care Alliance NHS Group, National Institute for Health Research [NIHR] Greater Manchester and Thames Valley and South Midlands Clinical Research Networks, participating GP surgeries, the “Support through Mobile Messaging and digital health Technology for Diabetes” (SuMMiT-D) patient and public involvement panel, Mandy Sekhon for her thoughts on the early stages of analysis and the wider SuMMiT-D team. Funding: This publication presents independent research funded by the NIHR under its Programme Grants for Applied Research program (RP-PG-1214-20003). AF is supported by the NIHR Oxford Biomedical Research Centre and an NIHR Senior Investigator. LL is supported by the Scottish Chief Scientist Office. The views expressed are those of the authors and not necessarily those of the NIHR, or Department of Health and Social Care. The SuMMiT-D research team acknowledges the support of the NIHR Clinical Research Network.12718025engSDG 3 - Good Health and Well-beingAcceptabilitymHealthType 2 Diabetestext messagingR MedicineNational Institute for Health Research (NIHR)RP-PG-1214-20003Chief Scientist Office (CSO)RJournal article10.1186/s12913-021-06663-2211